首页|非小细胞肺癌(中晚期)小剂量紫杉醇同步放化疗的护理干预体会

非小细胞肺癌(中晚期)小剂量紫杉醇同步放化疗的护理干预体会

Nursing intervention of small dose paclitaxel synchronous chemotherapy and radiotherapy in non-small cell lung cancer (middle and advanced stage)

扫码查看
目的 观察小剂量紫杉醇同步放化疗在治疗中晚期非小细胞肺癌中的应用,分析其护理干预体会.方法 选取2014年2月~2017年3月台州市中心医院收治的31例中晚期非小细胞肺癌患者为研究对象,均给予患者小剂量紫杉醇同步放化疗方案治疗,根据患者不良反应选择针对性护理干预,观察本组患者治疗情况.结果 本组患者经治疗后出现程度不一的不良反应,临床给予心理、预防感染、饮食等方面护理干预,所有患者不良反应情况均有所减轻,并完成治疗程序.结论 小剂量紫杉醇同步放化疗与相应的护理干预应用于中晚期非小细胞肺癌中疗效确切,可有效缓解患者治疗中不良反应,为疾病预后提供保障.
Objective To observe the effect of low-dose paclitaxel concurrent chemotherapy of advanced non-small cell lung cancer in the application in the treatment, analysis of the nursing intervention. Methods From February 2014 to March 2017 in our hospital 31 cases of advanced non-small cell lung cancer patients as the research object, the patients were given low-dose paclitaxel concurrent radiotherapy chemotherapy in the treatment of patients with adverse reactions, according to the selection of targeted nursing intervention, observation of this group of patients. Results The degree of toxicity is the after treatment of the patients with psychological, clinical, prevention of infection, diet and other aspects of nursing intervention, all patients with adverse reactions were mitigated, and completed the treatment program. Conclusion Low dose paclitaxel concurrent radiotherapy and chemotherapy and the application of nursing intervention in advanced non-small cell lung cancer with precise, can effectively alleviate the adverse reaction in the treatment of patients, as a disease. It provides the guarantee for the prognosis of the disease and has practical value.

advanced non-small cell lung cancersmall dose paclitaxelconcurrent chemoradiotherapynursing intervention

徐媛媛、王赛赛、杨琪

展开 >

浙江省台州市中心医院(台州学院附属医院) 放疗科,浙江 台州 318000

中晚期非小细胞肺癌 小剂量紫杉醇 同步放化疗 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(10)
  • 4
  • 8